Statins use and female lung cancer risk in Taiwan
- PMID: 23272648
- PMCID: PMC3532353
- DOI: 10.3402/ljm.v7i0.20123
Statins use and female lung cancer risk in Taiwan
Abstract
In this present study, we found that the use of rosuvastatin with cumulative using duration >12 months could correlate with 2.8-fold increased risk of lung cancer in women. We did not have specific comments on these results. Further prospective clinical studies of statins use are needed to elucidate this issue.
Keywords: lung cancer; statins.
References
-
- Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: A population-based study. Medicine (Baltimore) 2010;89:295–9. - PubMed
-
- Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: A population-based cohort study in Taiwan. Am J Gastroenterol. 2011;106:1697–704. - PubMed
-
- Lai SW, Lin CH, Liao KF, Su LT, Sung FC, Lin CC. Association between polypharmacy and dementia in older people: A population-based case-control study in Taiwan. Geriatr Gerontol Int. 2012;12:491–8. - PubMed
-
- Khurana V, Bejjanki HR, Caldito G, Owens MW. Statins reduce the risk of lung cancer in humans: A large case-control study of US veterans. Chest. 2007;131:1282–8. - PubMed
-
- Cheng MH, Chiu HF, Ho SC, Yang CY. Statin use and the risk of female lung cancer: A population-based case-control study. Lung Cancer. 2012;75:275–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical